Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.18 - $0.86 $101,234 - $483,674
-562,412 Reduced 79.48%
145,237 $38,000
Q1 2022

May 11, 2022

BUY
$0.6 - $1.06 $5,710 - $10,089
9,518 Added 1.36%
707,649 $428,000
Q4 2021

Feb 11, 2022

SELL
$0.85 - $1.4 $1,793 - $2,954
-2,110 Reduced 0.3%
698,131 $631,000
Q3 2021

Nov 12, 2021

BUY
$1.33 - $1.77 $57,795 - $76,915
43,455 Added 6.62%
700,241 $931,000
Q2 2021

Aug 11, 2021

SELL
$1.41 - $1.94 $90,029 - $123,870
-63,851 Reduced 8.86%
656,786 $945,000
Q1 2021

May 13, 2021

SELL
$1.61 - $2.77 $27,838 - $47,896
-17,291 Reduced 2.34%
720,637 $1.3 Million
Q4 2020

Feb 09, 2021

BUY
$1.55 - $2.24 $43,183 - $62,406
27,860 Added 3.92%
737,928 $1.29 Million
Q3 2020

Nov 12, 2020

BUY
$1.91 - $3.08 $62,099 - $100,140
32,513 Added 4.8%
710,068 $1.38 Million
Q2 2020

Aug 12, 2020

BUY
$1.97 - $3.98 $546,726 - $1.1 Million
277,526 Added 69.38%
677,555 $1.87 Million
Q1 2020

May 06, 2020

BUY
$1.17 - $3.0 $18,923 - $48,522
16,174 Added 4.21%
400,029 $1.2 Million
Q4 2019

Feb 14, 2020

BUY
$1.16 - $1.42 $14,321 - $17,531
12,346 Added 3.32%
383,855 $472,000
Q3 2019

Nov 07, 2019

SELL
$1.21 - $1.65 $1,903 - $2,595
-1,573 Reduced 0.42%
371,509 $494,000
Q2 2019

Aug 12, 2019

BUY
$1.39 - $2.03 $33,168 - $48,439
23,862 Added 6.83%
373,082 $627,000
Q1 2019

May 14, 2019

BUY
$1.39 - $1.71 $13,855 - $17,045
9,968 Added 2.94%
349,220 $524,000
Q4 2018

Feb 11, 2019

SELL
$1.41 - $2.16 $6,519 - $9,987
-4,624 Reduced 1.34%
339,252 $489,000
Q3 2018

Nov 09, 2018

SELL
$1.86 - $2.18 $23,151 - $27,134
-12,447 Reduced 3.49%
343,876 $0
Q2 2018

Aug 06, 2018

BUY
$1.76 - $2.79 $43,016 - $68,190
24,441 Added 7.36%
356,323 $701,000
Q1 2018

May 15, 2018

BUY
$1.34 - $2.03 $29,536 - $44,745
22,042 Added 7.11%
331,882 $607,000
Q4 2017

Feb 09, 2018

BUY
$1.65 - $2.45 $511,236 - $759,108
309,840
309,840 $561,000

About ATHERSYS, INC


  • Ticker ATHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 305,110,016
  • Market Cap $3.05M
  • Description
  • Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...
More about ATHX
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.